ArticlePloS one2022

Bayesian modeling and simulation to inform rare disease drug development early decision-making: Application to Duchenne muscular dystrophy.

Janelle L Lennie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.